Wellgistics Health, Inc. · NASDAQ:WGRX
Wellgistics Health — Investor Presentation (September 2025)
30 slides from Wellgistics Health's investor presentation, Sep 8, 2025
Slide 1: Redefining prescription access across America
W Wellgistics Health" Redefining prescription access across America oe Investor Presentation September 2025 Avertically integrated, operator-run platform combining scale and technology to replace legacy middlemen with direct, transparent access to prescriptions. wellgisticshealth.com
Slide 2: Today's Pharmaceutical Landscape
Today’s Pharmaceutical Landscape © The Problem: An outdated, bloated system—1 Independent pharmacies &, +. are closing at 1,000+ per Red Tm _year—suffocated by spread $600B+ U.S. drug market — but top six pricing and clawbacks.’ PBMs control over 95%, extract hidden fees, and block competition.* 4 D
Slide 3: 82% of adults believe prescription drug costs are unreasonable
S WY’ Wellgistics Health” 82% of adults believe the cost of prescription drugs is unreasonable Patients ° have had ® 1in3 adults skip treatments because their drugs enoug h cost too much Sources: KFF; SIA Group 3 WELLGISTICSHEALTH.com INVESTOR DECK ~ CONFIDENTIAL
Slide 4: The market is broken
J WY Wellgistics Health” 99% of employers believe drug prices are the [=I biggest threat to healthcare affordability.’ The market is bro ke n «fil Pharmaceutical costs spiraling out of control +15% per annum’ sources: 4, Flerce Healthcare, National Aliance Health 2. HHS, Investopedia 4 WeLLetsTicsHE
Slide 5: The Broken Pharmaceutical Drug Supply Chain
Wellgistics Health PROBLEM The Broken Pharmaceutical Drug Supply Chain T @ MARKET CHOKE POINT Ps Manufacturers Pharmacies Patients Employers Value lost in PBM rebates, Independents squeezed by Lack of coverage, prior Pharmacy spend rising 8- excessive distributor fees, PBMs through spread authorizat
Slide 6: Landmark support for PBM reform at Federal & State level
6 Landmark support for PBM reform at Federal & State level Current administration has clearly expressed its support for: Lowering the cost of 900 Fair, transparent & prescription drugs alll open markets eal Patient costs transparency RO) Health equity with = patient access Open competition Fie © Wel
Slide 7: Market Opportunity Overview
TAM - TOTAL ADDRESSABLE MARKET. Ee) $600B U.S. Prescription Drug Market (2024)* WY’ Wellgistics Health a | SAM ~ SERVICEABLE ADDRESSABLE MARKET d=] $300+B Employer Prescription Drug Spending* MARKET Market Opportunity Overview SOM - SERVICEABLE OBTAINABLE MARKET : ~@, ~19,000 MG} Independent Pharmac
Slide 8: Our Three Verticals
W’ Wellgistics Health Our Three Verticals THIS ECOSYSTEM HAS THREE COMPONENTS: Wellgistics W Wellgistics Wellgistics Distribution” Pharmacy” Tech & Hub" Distribution Arm Comprised of a licensed wholesale facility that buys direct from over 200 pharma manufacturers and supplies inventory to more than
Slide 9: About Us
WY’ Wellgistics Health About Us © Founder-led (2017-2024): 2024 Integration: IPO on NASDAQ: Brian Norton established Wellgistics to Merged into Wellgistics Health and completed Listed under ticker WGRX on empower independent pharmacies key acquisitions: Community Specialty February 21, 2025 Pharmacy
Slide 10: The WGRX Ecosystem
Ny SOLUTION MANUFACTURER The WGRX Eco Een \& Direct-to- Empowered Patient Rail: Independents: Cuts out PBM New revenue + middlemen. fulfillment power. Transparent Better Pricing: Outcomes: Real-time cost visibility Faster fills, lower costs, for employers. higher adherence. WELLGISTICSHEALTH.COM CON
Slide 11: How It Works
11 WY’ Wellgistics Health” How It Works PATIENT FULFILLMENT OPTIONS We identify the best fulfillment path for each patient: © 49 State Licenses for In-House Pharmacy (non-commercial/cash pay) WELLGISTICSHEALTH.COM PARTNER NETWORK We partner with: © Employer Groups, Transparent PBMs, Insurance Carrie
Slide 12: Technology (Underlying Magic)
TECHNOLOGY (UNDERLYING MAGIC) The Rails of Modern Prescription Delivery 0 Optimizes digital flow through AI automation ‘e”. Wellgistics Hub id Pharmacy/Patient Route any drug, from a 4, Einstein Rx > Scrubs/qualifies diag matches to correct med 42 WELLGISTICSHEALTH.coM Nv CK — CONFIDENTIAL
Slide 13: Improve patient access with key components: AI
o Pa : W Wellgistics Health- IMPROVE PATIENT ACCESS WITH KEY COMPONENTS: Al Consent = 4 Al Enrollment & WELLGISTICS Al: Leveraging AI to make our process faster, simpler and easier © Launched in 2025 sok ro) HubRx Al integrated with our existing tech stack 43. WELLGISTICSHEALTH.cOM » INVESTOR DECK —
Slide 14: Business Model
BUSINES MODEL . &, DistRIBUTION CENTER: aE PHARMACY CENTER: Multi ple Sales of Rx Products to Pharmacies DTP, Fulfillment Models, White Label, Cash Pay, Telemedicine Revenue Streams MODEL: High-Volume Distribution + Recurring SaaS = le Revenue, Low Dilution Growth A tus services: @ TECHNOLOGY: Fees
Slide 15: Competition / Differentiators
w 15 COMPETITION / DIFFERENTIATORS Why We Win =| PBMs/Big 3: ©® Opaque rebates © Spread pricing ©® Misaligned incentives WELLGISTICSHEALTH.COM WGRX ) Transparent ) Al-driven ) Vertically integrated ) Aligned with all stakeholders Proprietary routing (Wellgistics Hub) HubRx Al Al underwriting (Einste
Slide 16: Traction
w TRACTION Proven Growth & Strategic Wins: oP 2025 Half Year Growth WELLGISTICSHEALTH.COM 6,500+ § 4 200+ Total Pharmacies engaged Manufacturers to date 12,500+ 8 S631 Total Products/NDC's Pharmacies added in Q1 & Q2 ©, $18.65\V 2 2025 Q1 + Q2 Pro Forma Full Stack Tech Platforms: Revenue EINSTEIN RX
Slide 17: Expand our vertically integrated pharmacy and distribution network
Expand our vertically integrated pharmacy and distribution network WELLGISTICSHEALTH.COM Accelerate direct-to-patient (DTP) programs with manufacturer partnerships to deliver lower-cost, higher-access prescriptions Deploy Wellgistics Hub's Al- powered technologies like HubRx Al and Einstein Rx at na
Slide 18: Expert Leaders in Growth Execution
aed Brian Norton ceo W’ Wellgistics Health: Expert Leaders in Growth Execution ie Tony Madsen coo y7 Mark DiSiena CPA, Attorney, MBA Srini Kalla cio Entrepreneur and healthcare founder with 20% years of experience in healthcare distribution, technology, venture capital, and MEA. ‘Managing Partner of
Slide 19: Maker — Taker: Direct-to-Patient, By Design
9) WY Wellgistics Health” Maker — Taker Direct-to-Patient, By Design WRGX is a vertically integrated, Al-powered PBM alternative Positioned at the nexus of distribution, Al tech, and employer carve-outs Clear pathway to scale with transparent, end-to-end prescription rails Strategic capital partners
Slide 20: Wellgistics Health
é W Wellgistics Health © WELLGISTICSHEALTH.COM
Slide 21: Legal Disclaimer
21 fo) Legal Disclaimer Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that reflect current views of the Company with respect to, among other things, operations and financial per
Slide 22: Legal Disclaimer
22 Legal Disclaimer Notice to Investors ‘The information set forth in this presentation has been prepared for informational purposes and dees nat constitute any offer to sell or the solicitation of an offer to buy any ofthe Company's securities, nor will there be any sales ofthe Company's securities
Slide 23: Appendix
W’ Wellgistics Health” a) Appendix 23. WELLGISTICSHEALTH.coM INVESTOR DECK — CONFIDENTIAL
Slide 24: Board of Directors
W’ Wellgistics Health’ Board of Directors Don Anderson Previously the Presiden & CEO of Independent Pharmacy of Pharmacy Networks and Choice Rx Solutions Education: Bachelor of Science in Business, Master of Businss Adminstration from Chadwick University WELLGISTICSHEALTH.COM | a Suren Ajjarapu 1rd
Slide 25: Unified Tech Platform
Ww Unified Tech ° Platform Our fully-integrated ecosystem connects every touchpoint, enabling: e i ar Seamless Pharmacy Direct Manufacturer Operations Fulfillment Ee Full Patient Savings Better Patient Transparency Access 25 WELLGISTICSHEALTH.COM Lo aa J HubRx AI WwW Wellgistics Health" INVESTOR DEC
Slide 26: Monetization across the entire ecosystem
ac Monetization across the entire Pharmacy mj» Proprietary cOn pNeoerk EB, Employer y Pharmacy Subscription Wholesaling = Technology Fe) Bae) oral /> WELLGISTICs H.coM INVESTOR DECK — CONFIDENTIAL
Slide 27: Pioneering the Path for Blockchain in Healthcare
ac Pioneering the Path for Blockcha har BRIEF OVERVIEW OF XRP XRPis a real-time digital asset designed for fast, secure, low-cost global payments. Unlike Bitcoin or Ethereum, XRP was purpose-built for enterprise financial transactions—settling in seconds with near- zero fees. WELLGISTICS HEALTH'S PU
Slide 28: Wellgistics Distribution
W Wellgistics Distribution” CORE VERTICAL SERVICES: Distribution 28 — wettersticsHeaLTH.com 40,000 sq ft licensed wholesale facility in full FDA, NABP & DSCSA compliance Licensed to operate in all 50 states Serialized ERP technology for end-to- end drug tracking - Rapid fulfillment with just-in- tim
Slide 29: Wellgistics Pharmacy & Network
29 W Well CORE VERTICAL SERVICES: Pharmacy & Network WELLGISTICSHEALTH.COM 8 Full In-house Dispensing Pharmacy in 49 states 6,500+ Pharmacy Partners nationwide Custom packaging & white-label fulfillment programs INVESTOR DECK — CONFIDENTIAL eB DTP delivery + tracking Specialized programs for diabete
Slide 30: Wellgistics Tech & Hub
W Wellgistics Tech & Hub™ Einstein Rx - Real-time & analytics for prescribers, payers, and pharmacies CORE VERTICAL SERVICES: Tech & Hub Al Prior Auth, Al Benefit Verification, Al Copay Assistance HubRx Al - Al Technology Based SaaS, membership, licensing based monthly fees and services 30 Wettersti
Wellgistics Health — Investor Presentation (September 2025) on 6ix